Clinical Trial Update: Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of KBP-336 in obese individuals with osteoarthritis (knee); the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Osteoarthritis

Drugs mentioned

• KBP-336 (KBP-336)

Snippet

Sponsor: KeyBioscience AG | Conditions: Osteoarthritis in the Knee, Obesity | Phase 2 | Status: RECRUITING